(Q38547247)

English

Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales

scientific article published on 26 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales (English)

1 reference

Europe PubMed Central

4 September 2017

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Ruth Chapman

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christina Atchison

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Helen Johnson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Martin Cox

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

William John Edmunds

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mark Jit

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

26 January 2015

1 reference

Europe PubMed Central

4 September 2017

Medical Decision Making

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

633-647

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623063%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rotavirus and severe childhood diarrhea

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Impact of rotavirus vaccination on epidemiological dynamics in England and Wales.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

A mathematical model of the indirect effects of rotavirus vaccination.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Social contacts and mixing patterns relevant to the spread of infectious diseases

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Effectiveness of monovalent and pentavalent rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Indirect protection of adults from rotavirus by pediatric rotavirus vaccination

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Interpretation and estimation of vaccine efficacy under heterogeneity

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in Germany

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

An update to “The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Serological survey of anti-group A rotavirus IgM in UK adults

1 reference

https://api.crossref.org/works/10.1177%2F0272989X14566013

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38547247&oldid=1766579516"